A leader in pharmaceutical-grade cannabis manufacturing, this GMP-certified Jamaican company is offering a strategic equity opportunity to expand operations in Brazil and enter the U.S. Backed by exclusive supply agreements, global permits, and a low-cost Free Trade Zone location, this company is positioned to lead in both the pharmaceutical and medical cannabis markets.
Business Highlights:
Exclusive Market Access & Expansion Plans
- Has an exclusive 5-year supply agreement with Brazil’s state-owned pharma network, that serves over 40 million patients with full insurance coverage.
- Over 100 successful exports of pharmaceutical-grade THC to Brazil and the U.S.A.
- DEA import permits secured for U.S. market entry, aligned with the expected THC rescheduling in 2025.
- Plans to distribute directly to consumers and pharmacies in across U.S. states.
- Strategic joint venture in Brazil provides access to 13,000 pharmacies and 300,000 retail points across the country.
Operations, Facility & Financials
- $10M USD invested in a GMP-certified manufacturing facility located in Jamaica’s Free Trade Zone, offering duty-free exports and a 12.5% corporate tax rate.
- Facility supports compliant white-label production for U.S. brands.
- Projected revenue of $10.8M in 2025, then rising to $36.5M in 2026.
- Positive EBITDA forecasted by Q4 2025.
- A 5-year DCF valuation of $138M.
Leadership & Growth Potential
- This company is run by seasoned executives with backgrounds in pharma, cannabis, and consumer goods.
- They’re positioned to expand into additional global markets, including prescription psychedelics like psilocybin and ibogaine.
Market Opportunity
- Brazil cannabis market projected to reach $14.2B by 2030 (71.4% CAGR).
- U.S. market forecasted at $19.7B by 2030 (65.3% CAGR).
- U.S. growth potential offers significant upside not reflected in current valuation.
Investment Opportunity:
Invest in a fully operational cannabis company with strong connections, early access to the U.S. market, and a head start in Brazil. With key approvals, exclusive deals, and room to grow, this business is well-positioned to become a leading name in the global medical cannabis industry.
